{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:11:44Z","timestamp":1777734704770,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005241","name":"Institut de Recherche Clinique De Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clinbiochem.2025.110978","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:11:14Z","timestamp":1752567074000},"page":"110978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-7048","authenticated-orcid":false,"given":"Simon-Pierre","family":"Guay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Taschereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Desgagn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110978_b0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110978_b0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2025.110978_b0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-022-01525-5","article-title":"Elevated plasma triglyceride concentration and risk of adverse clinicaloutcomes in 1.5 million people: A CALIBER linked electronic health record study","volume":"21","author":"Patel","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110978_b0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/metabo13050621","article-title":"Severe Hypertriglyceridaemia and chylomicronaemia syndrome-causes, clinical presentation, and therapeutic options","volume":"13","author":"Bashir","year":"2023","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.110978_b0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of Hypertriglyceridemia","volume":"24","author":"Dron","year":"2020","journal-title":"Front Endocrinol (lausanne)."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2025.110978_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117489","article-title":"Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia","volume":"392","author":"Guay","year":"2024","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110978_b0040","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.jacl.2024.02.007","article-title":"Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome","volume":"18","author":"Guay","year":"2024","journal-title":"J. Clin. Lipidol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110978_b0045","doi-asserted-by":"crossref","first-page":"e2255","DOI":"10.1210\/clinem\/dgae103","article-title":"High hsCRP Concentration is associated with acute pancreatitis in multifactorial chylomicronemia syndrome","volume":"109","author":"Guay","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2025.110978_b0050","article-title":"Genetic determinants of pancreatitis risk in hypertriglyceridemia","author":"Paquette","year":"2024","journal-title":"Curr. Opin. Lipidol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2025.110978_b0055","article-title":"The Evolving Story of Multifactorial Chylomicronemia Syndrome","volume":"14","author":"Paquette","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110978_b0060","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1194\/jlr.M069948","article-title":"Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge","volume":"57","author":"Lai","year":"2016","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.clinbiochem.2025.110978_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13148-016-0304-4","article-title":"Epigenome-wide association study (EWAS) on lipids: The Rotterdam Study","volume":"7","author":"Braun","year":"2017","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0070","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1038\/s41598-017-09552-z","article-title":"Blood triglyceride levels are associated with DNA methylation at the serine metabolism gene PHGDH","volume":"7","author":"Truong","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13148-020-00957-8","article-title":"DNA methylation and lipid metabolism: An EWAS of 226 metabolic measures","volume":"13","author":"Gomez-Alonso","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110978_b0085","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4161\/epi.27981","article-title":"Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia","volume":"9","author":"Guay","year":"2014","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110978_b0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2013.03.033","article-title":"DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability","volume":"228","author":"Guay","year":"2013","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110978_b0095","first-page":"407","article-title":"A systematic review and metaanalysis of observational studies on the effects of epigenetic factors on serum triglycerides","volume":"66","author":"Mazaheri-Tehrani","year":"2022","journal-title":"Arch Endocrinol Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/epi.14.64","article-title":"A study in familial hypercholesterolemia suggests reduced methylomic plasticity in men with coronary artery disease","volume":"7","author":"Guay","year":"2015","journal-title":"Epigenomics"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110978_b0105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3892\/ijmm.2014.1692","article-title":"Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation","volume":"33","author":"Yamada","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001487","article-title":"Epigenetic patterns in blood associated with lipid traits predict incident coronary heart disease events and are enriched for results from genome-wide association studies","volume":"10","author":"Hedman","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13148-023-01533-6","article-title":"Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease","volume":"15","author":"Jin","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110978_b0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/CIRCULATIONAHA.121.055484","article-title":"Association of cardiovascular health through young adulthood with genome-wide DNA Methylation patterns in midlife: the CARDIA study","volume":"146","author":"Zheng","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2025.110978_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2025.110873","article-title":"DNA methylation levels may contribute to severe hypertriglyceridemia in multifactorial chylomicronemia syndrome","volume":"135","author":"Guay","year":"2025","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110978_b0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.110978_b0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11883-021-00962-z","article-title":"Clinical management of hypertriglyceridemia in the prevention of cardiovascular disease and pancreatitis","volume":"23","author":"Hernandez","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110978_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MED.0000000000000903","article-title":"An overview of persistent chylomicronemia: Much more than meets the eye","volume":"32","author":"Larouche","year":"2025","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacl.2010.11.004","article-title":"Etiology and risk of lactescent plasma and severe hypertriglyceridemia","volume":"5","author":"Tremblay","year":"2011","journal-title":"J. Clin. Lipidol."},{"issue":"15","key":"10.1016\/j.clinbiochem.2025.110978_b0155","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1101\/gad.916601","article-title":"CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin","volume":"15","author":"Osborne","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.clinbiochem.2025.110978_b0160","doi-asserted-by":"crossref","unstructured":"Cardona A, Day FR, Perry JRB, Loh M, Chu AY, Lehne B, Paul DS, Lotta LA, Stewart ID, Kerrison ND, Scott RA, Khaw KT, Forouhi NG, Langenberg C, Liu C, Mendelson MM, Levy D, Beck S, Leslie RD, Dupuis J, Meigs JB, Kooner JS, Pihlajam\u00e4ki J, Vaag A, Perfilyev A, Ling C, Hivert MF, Chambers JC, Wareham NJ, Ong KK. Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study. Diabetes. 2019 Dec, 68(12), 2315\u20132326. doi: 10.2337\/db18-0290. Epub 2019 Sep 10. PMID: 31506343; PMCID: PMC6868468.","DOI":"10.2337\/db18-0290"},{"issue":"8003","key":"10.1016\/j.clinbiochem.2025.110978_b0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","article-title":"Durable and efficient gene silencing in vivo by hit-and-run epigenome editing","volume":"627","author":"Cappelluti","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110978_b0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"14","key":"10.1016\/j.clinbiochem.2025.110978_b0175","article-title":"The impact of alcoholic drinks and dietary factors on epigenetic markers associated with triglyceride levels","volume":"15","author":"Lai","year":"2023","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110978_b0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/joim.13049","article-title":"Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes","volume":"288","author":"Ling","year":"2020","journal-title":"J. Intern. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110978_b0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2217\/epi-2020-0442","article-title":"Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetes","volume":"13","author":"Schrader","year":"2021","journal-title":"Epigenomics"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110978_b0190","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/ajcn\/nqaa233","article-title":"Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A","volume":"112","author":"Lai","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110978_b0195","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacl.2018.03.086","article-title":"Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service","volume":"12","author":"Zafrir","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.110978_b0200","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0022-2275(20)38428-5","article-title":"Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits","volume":"29","author":"Nordestgaard","year":"1988","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110978_b0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2006.09.015","article-title":"Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies","volume":"193","author":"Norata","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2025.110978_b0210","first-page":"111","article-title":"A risk factor for atherosclerosis: Triglyceride-rich lipoproteins","volume":"47","author":"Malloy","year":"2001","journal-title":"Adv. Intern. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110978_b0215","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199609193351203","article-title":"Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene","volume":"335","author":"Benlian","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110978_b0220","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: An under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass","year":"2020","journal-title":"J. Intern. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110978_b0225","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/ATVBAHA.122.318445","article-title":"Genetic testing for hypertriglyceridemia in academic lipid clinics: Implications for precision medicine-brief report","volume":"42","author":"Deshotels","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:11:50Z","timestamp":1777461110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":44,"alternative-id":["S0009912025001079"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110978","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110978"}}